About Us
Three founders. Three perspectives. One shared conviction: cancer vaccine development needs to become more connected.
Our Story
Oncocine was founded on the belief that effective cancer treatments require more than one perspective. Founded by three leaders with complementary experience across tumour biology, translational medicine and AI infrastructure; we have spent our careers building companies, developing cancer programmes and scaling computational systems inside pharma. We have seen how promising treatments can fail when these disciplines work in isolation.
We started Oncocine to connect them, combining decades of experience across oncology, translational medicine and AI to develop smarter, more adaptable cancer vaccines.
Vision
From rare to common, a vaccine for every cancer.
Mission
Our mission is to transform cancer vaccine development by decoding tumour biology and designing more adaptive, manufacturing-ready vaccines for patients with limited treatment options.
Build the future of cancer vaccines with us.
We're looking for partners and investors who share our ambition to expand cancer vaccines across multiple tumour types.
Get in Touch